1003-3734
2010 Issue 13
..............page:1156
CYP3A4-mediated synergistic effects on HIV-1 protease inhibitors
yao yao1; hu zhuo-han1; 2; 3(1 shanghai institute of pharmaceutical industry; shanghai 201203; china; 2 research institute for liver discases(shanghai) co.; ltd; shanghai 201203; china; 3 shanghai university of chinese traditional medicines; shanghai 201203; china)
yao yao1; hu zhuo-han1; 2; 3(1 shanghai institute of pharmaceutical industry; shanghai 201203; china; 2 research institute for liver discases(shanghai) co.; ltd; shanghai 201203; china; 3 shanghai university of chinese traditional medicines; shanghai 201203; china)
..............page:1124-1127
Cut the institutional costs should be the key to solve the problem of virtual-high medicine price
song rui-lin; zhang zheng-guang; ding shu-juan(china pharmaceutical industry research and development association; beijing 100120; china)
song rui-lin; zhang zheng-guang; ding shu-juan(china pharmaceutical industry research and development association; beijing 100120; china)
..............page:1103-1107
Preparation of self-microemulsifying semi-solid matrix hard capsules of daidzein
han xiao; wang dong-kai; zhang xiao-jun; wang yu; sun nian; liu xiang-nan(shenyang pharmaceutical university; shenyang 110016; china)
han xiao; wang dong-kai; zhang xiao-jun; wang yu; sun nian; liu xiang-nan(shenyang pharmaceutical university; shenyang 110016; china)
..............page:1180-1183
Preparation and evaluation of amorolfine hydrochloride ethosomes
wang hui; wei yu-hui; liu wen-jing; ma li; wu xin-an(department of pharmacy; first hospital of lanzhou university; lanzhou 730000; china)
wang hui; wei yu-hui; liu wen-jing; ma li; wu xin-an(department of pharmacy; first hospital of lanzhou university; lanzhou 730000; china)
..............page:1175-1179
Comparison of capecitabine plus oxaliplatin with 5-fluorouracil/leucovorin(5-FU/LV) plus oxaliplatin in the treatment of 75 patients with advanced colorectal cancer
yang yu-xian1; zhao shu-lin2; chen zhi-ming1; qiu xi-hui1; zhang sheng-qi1; zhuang xiao-wen1(1 department of oncology; 2 department of pharmacy; tumor hospital of shantou university medical college; shantou 515031; china)
yang yu-xian1; zhao shu-lin2; chen zhi-ming1; qiu xi-hui1; zhang sheng-qi1; zhuang xiao-wen1(1 department of oncology; 2 department of pharmacy; tumor hospital of shantou university medical college; shantou 515031; china)
..............page:1149-1152
Construction of vector expressing tyrosine kinase EphrinB2 ligand miRNA and evaluation of its gene silencing efficiency
pan jia-xin; zhang feng; wu xin-min; zhang zhi-wen(department of anesthesiology; peking university first hospital; peking university department of medicine; beijing 100034; china)
pan jia-xin; zhang feng; wu xin-min; zhang zhi-wen(department of anesthesiology; peking university first hospital; peking university department of medicine; beijing 100034; china)
..............page:1184-1188
Analgesic effect of parecoxib sodium used at different time points after uvulopalatopharyngoplasty
wang bing-shu; zhang li; yu bao-jin(department of anesthesiology; tianjin fourth central hospital; tianjin 300140; china)
wang bing-shu; zhang li; yu bao-jin(department of anesthesiology; tianjin fourth central hospital; tianjin 300140; china)
..............page:1145-1148
..............page:1160,1163,1170,1174,1183
Different application methods of cisatracurium impact extubation time in cardiac surgery with cardiopulmonary bypass
he xing-ying; shi xue-yin; yuan hong-bin; sun peng-ling; yan xiao-di(department of anesthesiology; changzheng hospital; shanghai 200003; china)
he xing-ying; shi xue-yin; yuan hong-bin; sun peng-ling; yan xiao-di(department of anesthesiology; changzheng hospital; shanghai 200003; china)
..............page:1142-1144
Analysis for unapproved reasons of new Chinese herbal drug registrations in recent years
zhu fei-peng; han wei(center for drug evaluation; state food and drug administration; beijing 100038; china)
zhu fei-peng; han wei(center for drug evaluation; state food and drug administration; beijing 100038; china)
..............page:1112-1115
Progress in drug therapies for infections with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
yue yang1; dong yu-ying1; yu zhi-ying2(1 china national pharmaceutical industry co.; ltd; beijing 100190; china; 2 people s hospital; peking university; beijing 100044; china)
yue yang1; dong yu-ying1; yu zhi-ying2(1 china national pharmaceutical industry co.; ltd; beijing 100190; china; 2 people s hospital; peking university; beijing 100044; china)
..............page:1131-1136,1152
Application of molecular imaging technology in drug development
xia zhen-na; che ai-ping; wang jie; yuan bo-jun; mao yu; lu guo-cai(center for new drug evaluation; second military medical university; shanghai 200433; china)
xia zhen-na; che ai-ping; wang jie; yuan bo-jun; mao yu; lu guo-cai(center for new drug evaluation; second military medical university; shanghai 200433; china)
..............page:1116-1120
Effects of penetration enhancers on in vitro percutaneous permeation of tea polyphenols liniment
wang dong1; han guo-zhu2; chen zhao-jun3(1 department of pharmacy; dalian hospital of dermatology; dalian 116021; china; 2 department of clinical pharmacology; dalian medical university; dalian 116044; china; 3 department of pharmacy; dalian children s hospital; dalian 116011; china)
wang dong1; han guo-zhu2; chen zhao-jun3(1 department of pharmacy; dalian hospital of dermatology; dalian 116021; china; 2 department of clinical pharmacology; dalian medical university; dalian 116044; china; 3 department of pharmacy; dalian children s hospital; dalian 116011; china)
..............page:1171-1174
Effect of GLP-1 on differentiation of intestinal epithelial cell line IEC-6 cells into insulin-secreting cells
wang wei; xiang ying; song hai-yan(department of endocrinology; the second affiliated hospital; haerbin medical university; haerbin 150086; china)
wang wei; xiang ying; song hai-yan(department of endocrinology; the second affiliated hospital; haerbin medical university; haerbin 150086; china)
..............page:1157-1160
Saxagliptin: a new dipeptidyl peptidase-Ⅳ inhibitor for the treatment of type 2 diabetes
tan ling; xia lu-feng; sun chun-hua(department of pharmacy; beijing hospital; the ministry of health; beijing 100730; china)
tan ling; xia lu-feng; sun chun-hua(department of pharmacy; beijing hospital; the ministry of health; beijing 100730; china)
..............page:1099-1102
Expression of GFP-PTP fusion protein and functional analysis of the HPV transformed cervical cancer cell membrane penetrating activity
zhong chun-yan1; 3; wang hu1; liu chang-bai1; huang yu-bin2(1 the institute of molecular biology; three georges university; yichang 443002; china; 2 state keylaboratory of polymer physics and chemistry; changchun institute of applied chemistry; chinese academy of sciences; changchun 130022; china; 3 hangzhou 3rd general hospital; hangzhou 310009; china)
zhong chun-yan1; 3; wang hu1; liu chang-bai1; huang yu-bin2(1 the institute of molecular biology; three georges university; yichang 443002; china; 2 state keylaboratory of polymer physics and chemistry; changchun institute of applied chemistry; chinese academy of sciences; changchun 130022; china; 3 hangzhou 3rd general hospital; hangzhou 310009; china)
..............page:1164-1170
..............page:1094
Chiral separation of ornidazole enantiomers by high performance liquid chromatography
yin yan-jie1; zhang qi-ming2; yuan zhe1(1 harbin testing center for food and drug; harbin 150525; china; 2 national institute for the control of pharmaceutical and biological products; beijing 100050; china)
yin yan-jie1; zhang qi-ming2; yuan zhe1(1 harbin testing center for food and drug; harbin 150525; china; 2 national institute for the control of pharmaceutical and biological products; beijing 100050; china)
..............page:1161-1163
Comparison of converting efficacy and safety of intravenous ibutilide and propafenone in Chinese patients with atrial fibrillation and atrial flutter
wu ying1; 2; jiang wen2; yan xiao-wei3; hu da-yi4; liu xiao-hui5; jia san-qing6; fan wei-hu7; cai nai-sheng8; wu zong-gui9; chen jun-zhu10; shan jiang11; he zhen-shan12; li guang-ping13; li yi-shi2(1 peking union medical college; chinese academy of medical sciences; beijing 100730; china; 2 key laboratory of clinical trial research in cardiovascular drugs; ministry of health; cardiovascular institute and fuwai hospital; peking union medical college and chinese academy of medical sciences; beijing 100037; china; 3 department of cardiology; peking union medical college hospital; beijing 100730; china; 4 people s hospital of peking university; beijing 100044; china; 5 beijing anzhen hospital; capital medical university; beijing 100029; china; 6 beijing friendship hospital; capital medical university; beijing 100050; china; 7 huashan hospital; fudan university; shanghai 200040; china; 8 zhongshan hospital; fudan university; shanghai 200032; china; 9 shanghai changzheng hospital; shanghai 200003; china; 10 the first hospital of college of medical sciences; zhejiang university; hangzhou 310003; china; 11 the second hospital of college of medical sciences; zhejiang university; hangzhou 310009; china; 12 bethune international peace hospital; shijiazhuang 050082; china; 13 the second hospital of tianjin medical university; tianjin 300211; china)
wu ying1; 2; jiang wen2; yan xiao-wei3; hu da-yi4; liu xiao-hui5; jia san-qing6; fan wei-hu7; cai nai-sheng8; wu zong-gui9; chen jun-zhu10; shan jiang11; he zhen-shan12; li guang-ping13; li yi-shi2(1 peking union medical college; chinese academy of medical sciences; beijing 100730; china; 2 key laboratory of clinical trial research in cardiovascular drugs; ministry of health; cardiovascular institute and fuwai hospital; peking union medical college and chinese academy of medical sciences; beijing 100037; china; 3 department of cardiology; peking union medical college hospital; beijing 100730; china; 4 people s hospital of peking university; beijing 100044; china; 5 beijing anzhen hospital; capital medical university; beijing 100029; china; 6 beijing friendship hospital; capital medical university; beijing 100050; china; 7 huashan hospital; fudan university; shanghai 200040; china; 8 zhongshan hospital; fudan university; shanghai 200032; china; 9 shanghai changzheng hospital; shanghai 200003; china; 10 the first hospital of college of medical sciences; zhejiang university; hangzhou 310003; china; 11 the second hospital of college of medical sciences; zhejiang university; hangzhou 310009; china; 12 bethune international peace hospital; shijiazhuang 050082; china; 13 the second hospital of tianjin medical university; tianjin 300211; china)
..............page:1137-1141
Inspirations of the regulatory policies on post-marketed health products in Singapore to China
chen lei1; liu meng2; zhang lu3; huang qin2(1 national institute for the control of pharmaceutical and biological products; beijing 100050; china; 2 state food and drug administration; beijing 100810; china; 3 china center for pharmaceutical international exchange; beijing 100082; china)
chen lei1; liu meng2; zhang lu3; huang qin2(1 national institute for the control of pharmaceutical and biological products; beijing 100050; china; 2 state food and drug administration; beijing 100810; china; 3 china center for pharmaceutical international exchange; beijing 100082; china)
..............page:1108-1111
Application of dexmedetomidine in the anesthetic management of functional neurosurgical procedures
xu ting; li min(department of anesthesia; peking university third hospital; beijing 100191; china)
xu ting; li min(department of anesthesia; peking university third hospital; beijing 100191; china)
..............page:1128-1130,1148
Isolation and identification of major impurities during synthesis of the andrographolide derivative AL-1
wang ding-yuan1; wang zhong-li2; wang yu-qiang2; yu pei1; 2(1 school of chemistry & chemical engineering; guangzhou university; guangzhou 510006; china; 2 institute of new drug research; jinan university college of pharmacy; guangzhou 510632; china)
wang ding-yuan1; wang zhong-li2; wang yu-qiang2; yu pei1; 2(1 school of chemistry & chemical engineering; guangzhou university; guangzhou 510006; china; 2 institute of new drug research; jinan university college of pharmacy; guangzhou 510632; china)
..............page:1121-1123
Optimization and evalution of all-trans retinoic acid ethosomes
li zhi; hu yu-rong; guo xin-hong(college of pharmacy; zhengzhou university; zhengzhou 450001; china)
li zhi; hu yu-rong; guo xin-hong(college of pharmacy; zhengzhou university; zhengzhou 450001; china)
..............page:1153-1156
Analysis of systemic fungal infections in ICU in our hospital
liang jin-mei; sun yan; zhu man(department of pharmaceutical care; pla general hospital; beijing 100853; china)
liang jin-mei; sun yan; zhu man(department of pharmaceutical care; pla general hospital; beijing 100853; china)
..............page:1189-1192
..............page:1097-1098